Dyslipidaemia in endocrine disorders
- PMID: 38160791
- PMCID: PMC11019327
- DOI: 10.1016/j.ihj.2023.12.012
Dyslipidaemia in endocrine disorders
Abstract
Lipid disorders are common in several endocrine conditions. Diabetes mellitus, hypothyroidism and Cushing's syndrome are the common endocrine disorders with dyslipidemia. Dyslipidemia has a significant impact on endocrine and metabolic health and the risk of atherosclerotic cardiovascular disease. In most cases of dyslipidemia, the suspicion of endocrine diseases must be based on clinical symptoms and signs. Optimal management of the dyslipidemia requires treatment of the underlying endocrine condition. Lipid lowering therapy is a useful adjunct or a requirement in many cases. The Indian guidelines provide a pragmatic and practical approach to the management of lipid disorders in endocrine disease, as well as endocrine vigilance with lipid therapy.
Keywords: Endocrine disorders; Lipid disorders; dyslipidemia.
Copyright © 2023. Published by Elsevier, a division of RELX India, Pvt. Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Feingold K., Brinton E.A., Grunfeld C. In: Endotext [Internet] De Groot L.J., Choruses G., Dungan K., Feingold K.R., Grossman A., Hershman J.M., editors. MDText.com, Inc.; South Dartmouth (MA): 2000. The effect of endocrine disorders on lipids and lipoproteins.
-
- Ł Bułdak, Marek B., Kajdaniuk D., et al. Endocrine diseases as causes of secondary hyperlipidemia. Endokrynol Pol. 2019;70(6):511–519. - PubMed
-
- Newman C.B., Blaha M.J., Boord J.B., et al. Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2020;105(12):dgaa674. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
